Skip to main content
Ineos Oxford Institute for Antimicrobial Research

About the IOI

The Ineos Oxford Institute for Antimicrobial Research (IOI) was established at the University of Oxford in January 2021 to advance research, education and collaboration in search of solutions to one of the biggest public health challenges of our time.

Our mission is to lead science that will enable the development new of antibiotics and provide the evidence to support transformational change in how we address antimicrobial resistance, to prevent the unthinkable from becoming the inevitable.

The IOI operates under three main pillars of activity:

In the lab

We undertake the basic science to produce novel molecules and compounds that will act as alternatives to the current limited “medicine cabinet” of antibiotics.

In the field

We survey, model and assess the global AMR burden to discover new ways to prevent and treat drug-resistant infections.

With the public

We work with government, industry and practitioners worldwide to inform citizens and galvanise actions that will prevent the spread of antimicrobial resistance.

Research Focus

About the Institute